Francis Willard Sarena, Chief Strategy Officer at FIVE PRIME THERAPEUTICS INC (FPRX), sold 3,636 shares at $47.39 ($172K) on 2017-01-18, disclosed to the SEC on 2017-01-18.
Open-market sale of $172k FPRX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FPRX | SELL | 2016-03-31 | $622K | — | Filing → |
| FPRX | SELL | 2016-01-29 | $1.1M | — | Filing → |